Your browser doesn't support javascript.
loading
Challenges facing drug utilization research in the Latin American region.
Salas, Maribel; Lopes, Luciane C; Godman, Brian; Truter, Ilse; Hartzema, Abraham G; Wettermark, Bjorn; Fadare, Joseph; Burger, Johanita R; Appenteng, Kwame; Donneyong, Macarius; Arias, Ariel; Ankrah, Daniel; Ogunleye, Olayinka O; Lubbe, Martha; Horne, Laura; Bernet, Jorgelina; Gómez-Galicia, Diana L; Del Carmen Garcia Estrada, Miriam; Oluka, Margaret N; Massele, Amos; Alesso, Luis; Herrera Comoglio, Raquel; da Costa Lima, Elisangela; Vilaseca, Carmen; Bergman, Ulf.
Affiliation
  • Salas M; Daiichi Sankyo, Inc, Basking Ridge, USA.
  • Lopes LC; CCEB/CPeRT, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
  • Godman B; Pharmaceutical Science graduate Course, Universidade de Sorocaba UNISO, Sao Paulo, Brazil.
  • Truter I; Karolinska Institute, Stockholm, Sweden.
  • Hartzema AG; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Gainesville, Glasgow, UK.
  • Wettermark B; School of Pharmacy, Sefako Makgatho Health Sciences University, Garankuwa, South Africa.
  • Fadare J; Drug Utilization Research Unit (DURU), Department of Pharmacy, Nelson Mandela University, South Africa.
  • Burger JR; College of Pharmacy, Gainesville, FL.
  • Appenteng K; Clinical epidemiology & Clinical pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Donneyong M; Department of Pharmacy, Disciplinary Domain of Medicine and Pharmacy, Uppsala University.
  • Arias A; Department of Pharmacology and Therapeutics, Ekiti State University College of Medicine, Ado-Ekiti, Nigeria.
  • Ankrah D; Medicine Usage in South Africa (MUSA), North-West University, Potchefstroom, South Africa.
  • Ogunleye OO; Department of Epidemiology, Astellas Pharma US, Northbrook, IL.
  • Lubbe M; Pharmacy Practice and Science, College of Pharmacy, The Ohio State University, Columbus, Ohio.
  • Horne L; Centre for Biologics Evaluation, Health Canada, Ottawa, ON and Faculty of Pharmacy, Université de Montréal, Montreal, QC, Canada.
  • Bernet J; Korle-Bu Teaching Hospital, Accra, Ghana.
  • Gómez-Galicia DL; Department of Pharmacology, Therapeutics and Toxicology, Lagos State University College of Medicine, Ikeja, Lagos, Nigeria.
  • Del Carmen Garcia Estrada M; Medicine Usage in South Africa (MUSA), North-West University, Potchefstroom, South Africa.
  • Oluka MN; Department of Epidemiology, Daiichi Sankyo, Inc, Basking Ridge, NJ.
  • Massele A; School of Medicine, Cordoba National University, Cordoba, Argentina.
  • Alesso L; Facultad de Farmacia, Universidad Autónoma del Estado de Morelos, Cuernavaca, México.
  • Herrera Comoglio R; Facultad de Ciencias Medicas, Universidad de San Carlos de Guatemala, Guatemala, Guatemala.
  • da Costa Lima E; School of Pharmacy, University of Nairobi, Nairobi, Kenya.
  • Vilaseca C; Faculty of Medicine, University of Botswana, Gaborone, Botswana.
  • Bergman U; School of Medicine, Cordoba National University, Cordoba, Argentina.
Pharmacoepidemiol Drug Saf ; 29(11): 1353-1363, 2020 11.
Article in En | MEDLINE | ID: mdl-32419226

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Utilization / Motivation Limits: Humans Language: En Journal: Pharmacoepidemiol Drug Saf Journal subject: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2020 Document type: Article Affiliation country: United States Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Utilization / Motivation Limits: Humans Language: En Journal: Pharmacoepidemiol Drug Saf Journal subject: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2020 Document type: Article Affiliation country: United States Country of publication: United kingdom